Trials / Conditions / Erythrodermic Psoriasis
Erythrodermic Psoriasis
5 registered clinical trials studyying Erythrodermic Psoriasis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis NCT06801028 | Jinnah Postgraduate Medical Centre | — |
| Active Not Recruiting | A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis NCT06323356 | Takeda | Phase 3 |
| Active Not Recruiting | A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic NCT06295692 | Janssen Pharmaceutical K.K. | Phase 3 |
| Completed | Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) NCT03885089 | Pfizer | — |
| Completed | A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythroderm NCT03942042 | Eli Lilly and Company | Phase 4 |